Delayed pericardial effusion or tamponade following left atrial appendage closure: A single-center experience

• Published in: Journal of the Formosan Medical Association Vol. 122; no. 8; pp. 707 - 713
• Main Authors: Fu, Guohua, He, Bin, Chu, Huimin, Wang, Binhao, Pan, Yuning, Xie, Binhua, Feng, Mingjun, Du, Xianfeng, Zhuo, Weidong, Qi, Yingbo
• Format: Journal Article
• Language: English
• Published: Singapore Elsevier B.V 01.08.2023; Elsevier
• Subjects: Atrial Appendage - surgery; Atrial Fibrillation - complications; Atrial Fibrillation - surgery; Cardiac Surgical Procedures - adverse effects; Delayed PE/PT; Fibrinolytic Agents; Humans; Left atrial appendage closure; Pericardial effusion; Pericardial Effusion - complications; Pericardial Effusion - etiology; Pericardial tamponade; Pericardiocentesis; Stroke - etiology; Treatment Outcome; Pericardial tamponade; Delayed PE/PT; Pericardiocentesis; Left atrial appendage closure; Pericardial effusion
• ISSN: 0929-6646; 1876-0821
• DOI: 10.1016/j.jfma.2022.11.010

Pericardial effusion or pericardial tamponade (PE/PT) is a relatively common complication of left atrial appendage closure (LAAC). However, delayed PE/PT is rare with limited data. The aim of the study was to analyze the incidence and clinical consequences of delayed PE/PT following LAAC. Patients with nonvalvular AF who were successfully implanted with LAAC devices from October 2014 to April 2021 were consecutively screened. Subjects experiencing delayed PE/PT after LAAC were included. All treatment sessions of the subjects were recorded in detail. After discharge, the patients were followed up for clinical outcomes. A total of 748 patients with successful LAAC [nitinol cage device (475 Watchman 2.5), nitinol plug device (131 ACP and 142 LAmbre)] were screened. Six patients experienced delayed PE/PT (1 Watchman, 2 ACP, 3 LAmbre). The incidence of delayed PE/PT was higher in patients with a nitinol plug device (1.8% vs. 0.2%, P = 0.027). Bloody PE only occurred in patients with a nitinol plug device (5/273, 1.8%). All the patients accepted pericardiocentesis and discontinuing antithrombotic medication, and none of the patients died or needed cardiac surgery. All patients were followed up for 810 (598, 1174) days after discharge. None of them developed constrictive pericarditis or thromboembolic or major bleeding events. Delayed PE/PT is rare but can occur, and the incidence of delayed bloody PE/PT for the nitinol plug device was higher than that for the nitinol cage device. The strategy of emergency pericardiocentesis combined with discontinuing antithrombotic medication may be effective for delayed bloody PE/PT.